Tegafur–uracil is a safe alternative for the treatment of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: a proof of principle

OBJECTIVE: The objective of this study was to evaluate the safety of using tegafur–uracil (UFT) in colorectal cancer patients with partial dihydropyrimidine dehydrogenase (DPD) deficiency. PATIENTS AND METHODS: The study included five colorectal cancer patients who presented with acute toxicity (gra...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Cubero, Daniel I.G., Cruz, Felipe Melo, Santi, Patrícia, Silva, Ismael Dale C.G., del Giglio, Auro
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2012
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3384092/
https://ncbi.nlm.nih.gov/pubmed/22754590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834012441049
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars